首页 | 本学科首页   官方微博 | 高级检索  
     


Demographics,comorbidities, and outcomes among young and middle-aged COVID-19 patients in Saudi Arabia
Authors:Amer S. Alali  Abdulaziz O. Alshehri  Ahmed Assiri  Shahd Khan  Munirah A. Alkathiri  Omar A. Almohammed  Waleed Badoghaish  Saeed M. AlQahtani  Musaad A. Alshammari  Mohamed Mohany  Faisal F. Alamri  Yazed AlRuthia  Faleh Alqahtani
Affiliation:1. Department of Pharmaceutics, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj 11942, Saudi Arabia;2. Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia;3. General Directorate of Clinical Excellence, Assistant Deputy of Planning and Organizational Excellence, Ministry of Health, Riyadh, Saudi Arabia;4. Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia;5. Department of Internal Medicine, College of Medicine, University of Tabuk, Tabuk, Saudi Arabia;6. Department of Prosthetic Dentistry, College of Dentistry, King Khalid University, Abha 62529, Saudi Arabia;7. Basic Sciences Department, College of Science and Health Professions (KSAU-HS), King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia;8. King Abdullah International Medical Research Center, Jeddah, Saudi Arabia;9. Pharmacoeconomics Research Unit, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia
Abstract:
The impact of different sociodemographic and clinical characteristics on the COVID-19-related morbidity and mortality rates have been studied extensively around the world; however, there is a dearth of data on the impact of different clinical and sociodemographic variables on the COVID-19-related outcomes in Saudi Arabia. This study aimed to identify those at high risk of worse clinical outcomes, such as hospitalization and longer length of stay (LOS) among young and middle-aged adults (18 to 55 years). In this questionnaire-based cross-sectional study, 706 patients with real-time polymerase chain reaction (RT-PCR) confirmed COVID-19 infection were interviewed. Patients’ demographic characteristics, dietary habits, medical history, and lifestyle choices were collected through phone interviews. Patients with chronic health conditions, such as diabetes and hypertension, reported a higher rate of hospitalization, ICU admission, oxygen-support needs, and a longer period of recovery and LOS. Multiple logistic regression showed that diabetes, hypertension, and pulmonary disease (e.g., asthma and chronic obstructive pulmonary disease (COPD)) were associated with a higher risk of hospitalization and longer LOS. Multiple logistic regression showed that symptoms of breathlessness, loss of smell and/or taste, diarrhea, and cough were associated with a longer recovery period. Similarly, breathlessness, vomiting, and diarrhea were associated with higher rates of hospitalization. The findings of this study confirm the similarity of the factors associated with worse clinical outcomes across the world. Future studies should use more robust designs to investigate the impact of different therapies on the COVID-19-related morbidity and mortality in Saudi Arabia.
Keywords:COVID-19  Coronavirus  SARS-CoV-2  Hypertension  Diabetes  Saudi Arabia
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号